| Literature DB >> 28125662 |
Zayed D Alsharari1, Ulf Risérus1, Karin Leander2, Per Sjögren1, Axel C Carlsson3, Max Vikström2, Federica Laguzzi2, Bruna Gigante2,4, Tommy Cederholm1, Ulf De Faire2,5, Mai-Lis Hellénius5, Matti Marklund1.
Abstract
Entities:
Mesh:
Substances:
Year: 2017 PMID: 28125662 PMCID: PMC5270324 DOI: 10.1371/journal.pone.0170684
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Anthropometrics, clinical measurements, lifestyle factors, serum cholesteryl ester FA, and estimated desaturase activity in the 60-year old men and women.
| Total (n = 3926) | Men (n = 1899) | Women (n = 2027) | ||
|---|---|---|---|---|
| Abdominal obesity (%) | 34 | 29 | 39 | <0.0001 |
| BMI (kg/m2) | 26.3 (23.9–29.1) | 26.6 (24.4–29.1) | 25.9 (23.4–28.9) | <0.0001 |
| SAD (cm) | 20.6±2.9 | 21.5±2.7 | 19.8±2.8 | <0.0001 |
| Waist circumference (cm) | 91.9±12.6 | 97.8±10.4 | 86.4±11.9 | <0.0001 |
| Waist-hip ratio | 0.89±0.09 | 0.95±0.06 | 0.83±0.07 | <0.0001 |
| SADHR (%) | 0.12±0.02 | 0.12±0.02 | 0.12±0.02 | 0.19 |
| WCHR (%) | 0.54±0.07 | 0.55±0.06 | 0.53±0.07 | <0.0001 |
| WHHR (m-1) | 0.52±0.05 | 0.54±0.04 | 0.51±0.05 | <0.0001 |
| Total Cholesterol (mmol/L) | 5.9 (5.3–6.6) | 5.8 (5.1–6.4) | 6.1 (5.4–6.8) | <0.0001 |
| LDL Cholesterol2 (mmol/L) | 3.9±0.9 | 3.8±0.9 | 3.9±1.0 | 0.019 |
| HDL Cholesterol (mmol/L) | 1.5±0.4 | 1.3±0.3 | 1.6±0.4 | <0.0001 |
| Triglycerides (mmol/L) | 1.1 (0.8–1.6) | 1.2 (0.9–1.7) | 1.1 (0.8–1.5) | <0.0001 |
| Fasting insulin (mU/L) | 8.8 (6.6–12.3) | 9.2 (6.8–13.4) | 8.5 (6.4–11.5) | <0.0001 |
| Fasting glucose3 (mmol/L) | 5.2 (4.9–5.7) | 5.4 (5.0–5.9) | 5.1 (4.7–5.5) | <0.0001 |
| Alcohol intake (g/day) | 8.7 (2.7–17.6) | 14.0 (6.7–26.5) | 5.1 (1.3–11.6) | <0.0001 |
| Physical activity (%) | <0.0001 | |||
| Sedentary | 11 | 11 | 12 | |
| Light intensity | 58 | 55 | 61 | |
| Medium intensity | 23 | 25 | 21 | |
| High intensity | 7 | 9 | 6 | |
| Smoking (%) | <0.0001 | |||
| Never | 40 | 34 | 46 | |
| Current | 21 | 20 | 22 | |
| Former | 39 | 46 | 32 | |
| Education (%) | 0.11 | |||
| ≤9 y | 28 | 27 | 30 | |
| 9–12 y | 44 | 45 | 43 | |
| >12 y | 28 | 28 | 27 | |
| Serum fatty acid, % of total FA | ||||
| Palmitic acid (PA, 16:0) | 11.4 (10.9–11.9) | 11.6 (11.1–12.0) | 11.2 (10.8–11.6) | <0.0001 |
| Linoleic acid (LA, 18:2n6) | 48.4±4.2 | 48.4±4.2 | 48.4±4.1 | 0.97 |
| Alpha-linolenic acid (ALA, 18:3n3) | 0.88±0.20 | 0.87±0.20 | 0.90±0.20 | <0.0001 |
| Eicosapentaenoic acid (EPA, 20:5n3) | 1.88 (1.46–2.47) | 1.87 (1.44–2.46) | 1.89 (1.47–2.49) | 0.33 |
| Docohexaenoic acid (DHA, 22:6n3) | 0.92±0.25 | 0.91±0.25 | 0.93±0.24 | 0.0065 |
| Desaturase activity, FA ratio | ||||
| SCD (16:1/16:0) | 0.30 (0.24–0.38) | 0.27 (0.22–0.35) | 0.32 (0.27–0.40) | <0.0001 |
| D5D (20:4n6/20:3n6) | 9.0±2.2 | 9.0±2.2 | 9.0±2.2 | 0.41 |
| D6D (18:3n6/18:2n6) | 0.018 (0.013–0.023) | 0.017 (0.013–0.023) | 0.018 (0.014–0.024) | 0.0059 |
Values are mean±SD, median (IQR), or %. D5D, Δ5-desaturase; D6D, Δ6-desaturase; FA, fatty acid; SAD, sagittal abdominal diameter; SADHR, sagittal abdominal diameter-to-height ratio; SCD, stearoyl-CoA desaturase; WCHR, waist circumference-to-height ratio; WHR, waist-hip ratio; WHHR, waist-hip-height ratio.
1Sex differences of continuous variables were assessed by Student’s t-test (normally distributed variables) or Wilcoxon-Mann-Whitney test (skewed variables), while sex difference in categorical variables were evaluated by χ2 test.
Associations of serum fatty acids with abdominal obesity.
| Quartile of serum fatty acid | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | Ptrend | Pnon-linear | |||
| Median (% of total FA) | 10.6 | 11.2 | 11.6 | 12.2 | ||||
| AO prevalence | 293 (30) | 313 (32) | 364 (37) | 370 (38) | ||||
| OR (95% CI) | ||||||||
| Sex-adjusted | 1.00 (reference) | 1.10 (0.91–1.34) | 1.39 (1.15–1.68) | 1.43 (1.19–1.73) | <0.0001 | 0.0097 | ||
| Mutivariable-adjusted | 1.00 (reference) | 1.10 (0.90–1.33) | 1.40 (1.15–1.70) | 1.46 (1.20–1.77) | <0.0001 | 0.0037 | ||
| Median (% of total FA) | 43.8 | 47.4 | 49.9 | 52.9 | ||||
| AO prevalence | 446 (45) | 358 (36) | 291 (30) | 245 (25) | ||||
| OR (95% CI) | ||||||||
| Sex-adjusted | 1.00 (reference) | 0.69 (0.57–0.82) | 0.50 (0.42–0.61) | 0.40 (0.33–0.48) | <0.0001 | <0.0001 | ||
| Mutivariable-adjusted | 1.00 (reference) | 0.69 (0.57–0.83) | 0.50 (0.41–0.61) | 0.40 (0.32–0.49) | <0.0001 | <0.0001 | ||
| Median (% of total FA) | 0.67 | 0.81 | 0.93 | 1.10 | ||||
| AO prevalence | 376 (38) | 333 (34) | 324 (33) | 307 (31) | ||||
| OR (95% CI) | ||||||||
| Sex-adjusted | 1.00 (reference) | 0.83 (0.69–0.99) | 0.79 (0.66–0.95) | 0.73 (0.61–0.88) | 0.0013 | 0.07 | ||
| Mutivariable-adjusted | 1.00 (reference) | 0.87 (0.72–1.05) | 0.80 (0.67–0.97) | 0.74 (0.61–0.89) | 0.0014 | 0.10 | ||
| Median (% of total FA) | 1.20 | 1.66 | 2.13 | 3.08 | ||||
| AO prevalence | 322 (33) | 361 (37) | 340 (35) | 317 (32) | ||||
| OR (95% CI) | ||||||||
| Sex-adjusted | 1.00 (reference) | 1.19 (0.99–1.44) | 1.09 (0.90–1.31) | 0.98 (0.81–1.18) | 0.39 | 0.32 | ||
| Mutivariable-adjusted | 1.00 (reference) | 1.24 (1.02–1.50) | 1.19 (0.98–1.44) | 1.09 (0.90–1.33) | 0.75 | 0.13 | ||
| Median (% of total FA) | 0.65 | 0.82 | 0.97 | 1.19 | ||||
| AO prevalence | 374 (38) | 345 (35) | 343 (35) | 278 (28) | ||||
| OR (95% CI) | ||||||||
| Sex-adjusted | 1.00 (reference) | 0.88 (0.73–1.06) | 0.87 (0.72–1.05) | 0.64 (0.53–0.77) | <0.0001 | 0.34 | ||
| Mutivariable-adjusted | 1.00 (reference) | 0.94 (0.78–1.14) | 0.97 (0.80–1.17) | 0.75 (0.62–0.92) | 0.0088 | 0.18 | ||
1FA, fatty acid; OR, odds ratio; SAD, sagittal abdominal diameter; WC, waist circumference; WHR, waist-hip ratio.
2P for overall trend (Ptrend) was evaluated using logistic regression models with sex-specific quartile median as exposure.
3P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines.
4Abdominal obesity was defined as WC>88 cm in women and WC>102 cm in men.
5OR and 95% CI were evaluated using logistic regression models.
6Adjusted for sex, physical activity, alcohol intake, education and smoking.
Fig 1Associations of serum palmitic acid (A) and linoleic acid (B) with abdominal obesity evaluated using restricted cubic spline. Associations were adjusted for sex, smoking, physical activity, education, and alcohol intake. Full and dashed lines represent odds ratios and their 95% CI, respectively, while dotted vertical lines correspond to 25th, 50th, and 75th percentiles of fatty acid proportions.
Associations of serum fatty acids with abdominal obesity,.
| Quartile of serum fatty acid | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | Ptrend | Pnon-linear | |||
| SAD, cm | Observed | 20.3 (20.2–20.5) | 20.5 (20.3–20.6) | 20.7 (20.5–20.9) | 20.9 (20.7–21.0) | <0.0001 | 0.005 | |
| Adjusted | 20.3 (20.2–20.5) | 20.5 (20.3–20.6) | 20.7 (20.5–20.9) | 20.9 (20.7–21.0) | <0.0001 | 0.002 | ||
| WC, cm | Observed | 90.6 (89.8–91.4) | 91.3 (90.6–92.1) | 92.5 (91.7–93.3) | 93.2 (92.4–94.0) | <0.0001 | 0.0031 | |
| Adjusted | 90.6 (89.9–91.3) | 91.3 (90.6–92.0) | 92.5 (91.8–93.2) | 93.2 (92.6–93.9) | <0.0001 | 0.0010 | ||
| WHR, cm | Observed | 0.88 (0.87–0.88) | 0.88 (0.88–0.89) | 0.89 (0.89–0.90) | 0.90 (0.89–0.90) | <0.0001 | 0.0023 | |
| Adjusted | 0.88 (0.88–0.88) | 0.88 (0.88–0.89) | 0.89 (0.89–0.89) | 0.90 (0.89–0.90) | <0.0001 | 0.0008 | ||
| SAD, cm | Observed | 21.3 (21.1–21.5) | 20.9 (20.7–21.1) | 20.3 (20.1–20.5) | 19.9 (19.7–20.0) | <0.0001 | <0.0001 | |
| Adjusted | 21.3 (21.1–21.5) | 20.9 (20.7–21.0) | 20.3 (20.2–20.5) | 19.9 (19.7–20.0) | <0.0001 | <0.0001 | ||
| WC, cm | Observed | 94.9 (94.1–95.7) | 93.0 (92.2–93.8) | 90.8 (90.1–91.6) | 88.9 (88.2–89.7) | <0.0001 | <0.0001 | |
| Adjusted | 94.9 (94.2–95.6) | 93.0 (92.3–93.6) | 90.8 (90.1–91.5) | 88.9 (88.2–89.6) | <0.0001 | <0.0001 | ||
| WHR, cm | Observed | 0.91 (0.90–0.91) | 0.89 (0.89–0.90) | 0.88 (0.88–0.89) | 0.87 (0.87–0.88) | <0.0001 | 0.0007 | |
| Adjusted | 0.91 (0.90–0.91) | 0.89 (0.89–0.89) | 0.88 (0.88–0.89) | 0.87 (0.87–0.88) | <0.0001 | 0.0011 | ||
| SAD, cm | Observed | 20.8 (20.6–21.0) | 20.6 (20.4–20.8) | 20.5 (20.3–20.7) | 20.4 (20.3–20.6) | 0.0011 | 0.21 | |
| Adjusted | 20.8 (20.6–21.0) | 20.6 (20.5–20.8) | 20.5 (20.3–20.7) | 20.4 (20.2–20.6) | 0.0012 | 0.42 | ||
| WC, cm | Observed | 92.9 (92.1–93.7) | 91.8 (91.0–92.6) | 91.5 (90.7–92.3) | 91.4 (90.7–92.1) | 0.0032 | 0.08 | |
| Adjusted | 92.8 (92.1–93.4) | 92.0 (91.3–92.7) | 91.5 (90.8–92.2) | 91.4 (90.7–92.1) | 0.004 | 0.17 | ||
| WHR, cm | Observed | 0.89 (0.89–0.90) | 0.89 (0.88–0.89) | 0.89 (0.88–0.89) | 0.89 (0.88–0.89) | 0.51 | 0.0062 | |
| Adjusted | 0.89 (0.89–0.89) | 0.89 (0.88–0.89) | 0.89 (0.88–0.89) | 0.89 (0.88–0.89) | 0.50 | 0.019 | ||
| SAD, cm | Observed | 20.4 (20.2–20.6) | 20.7 (20.5–20.9) | 20.7 (20.5–20.8) | 20.6 (20.4–20.7) | 0.62 | 0.0354 | |
| Adjusted | 20.4 (20.2–20.5) | 20.7 (20.5–20.8) | 20.7 (20.5–20.9) | 20.6 (20.4–20.8) | 0.13 | 0.0076 | ||
| WC, cm | Observed | 91.4 (90.6–92.2) | 92.3 (91.5–93.0) | 92.2 (91.4–93.0) | 91.8 (91.0–92.6) | 0.71 | 0.11 | |
| Adjusted | 91.1 (90.4–91.8) | 92.1 (91.4–92.8) | 92.3 (91.7–93.0) | 92.1 (91.4–92.8) | 0.11 | 0.0203 | ||
| WHR, cm | Observed | 0.89 (0.88–0.89) | 0.89 (0.89–0.90) | 0.89 (0.88–0.89) | 0.88 (0.88–0.89) | 0.10 | 0.42 | |
| Adjusted | 0.89 (0.88–0.89) | 0.89 (0.89–0.89) | 0.89 (0.88–0.89) | 0.89 (0.88–0.89) | 0.61 | 0.57 | ||
| SAD, cm | Observed | 20.8 (20.6–21.0) | 20.6 (20.4–20.8) | 20.6 (20.4–20.8) | 20.4 (20.2–20.6) | 0.0016 | 0.31 | |
| Adjusted | 20.7 (20.5–20.8) | 20.6 (20.4–20.8) | 20.6 (20.4–20.8) | 20.5 (20.3–20.7) | 0.18 | 0.17 | ||
| WC, cm | Observed | 92.5 (91.8–93.3) | 92.1 (91.3–92.9) | 91.8 (91.0–92.7) | 91.2 (90.4–91.9) | 0.0080 | 0.30 | |
| Adjusted | 92.1 (91.4–92.8) | 92.0 (91.3–92.7) | 91.9 (91.3–92.6) | 91.6 (90.9–92.3) | 0.45 | 0.14 | ||
| WHR, cm | Observed | 0.89 (0.89–0.90) | 0.89 (0.88–0.89) | 0.89 (0.88–0.89) | 0.88 (0.88–0.89) | <0.0001 | 0.61 | |
| Adjusted | 0.89 (0.89–0.90) | 0.89 (0.88–0.89) | 0.89 (0.88–0.89) | 0.88 (0.88–0.89) | 0.0144 | 0.91 | ||
1FA, fatty acid; SAD, sagittal abdominal diameter; WC, waist circumference; WHR, waist-hip ratio.
2Values are quartile means (95% CI).
3P for overall trend (Ptrend) was evaluated using linear regression models with sex-specific quartile median as exposure; for observed values sex was the only additional covariate, while for multivariable-adjusted trend sex, physical activity, alcohol intake, education and smoking were included as covariates.
4P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines
5Adjusted for physical activity, alcohol intake, education and smoking.
Associations of estimated desaturase activities with abdominal obesity.
| Quartile of estimated desaturase activity | |||||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | Ptrend | Pnon-linear | ||
| Median 16:1/16:0 ratio | 0.21 | 0.27 | 0.33 | 0.45 | |||
| AO prevalence | 190 (19) | 269 (27) | 405 (41) | 476 (49) | |||
| OR (95% CI) | |||||||
| Sex-adjusted | 1.00 (reference) | 1.58 (1.28–1.95) | 2.96 (2.42–3.63) | 4.00 (3.27–4.91) | <0.0001 | <0.0001 | |
| Multivariable-adjusted | 1.00 (reference) | 1.61 (1.29–1.99) | 3.01 (2.44–3.72) | 4.14 (3.33–5.15) | <0.0001 | <0.0001 | |
| Median 20:4n6/20:3n6 ratio | 6.71 | 8.11 | 9.49 | 11.46 | |||
| AO prevalence, n (%) | 431 (44) | 385 (39) | 289 (29) | 235 (24) | |||
| OR (95% CI) | |||||||
| Sex-adjusted | 1.00 (reference) | 0.82 (0.69–0.99) | 0.53 (0.44–0.64) | 0.40 (0.33–0.48) | <0.0001 | 0.0004 | |
| Multivariable-adjusted | 1.00 (reference) | 0.84 (0.70–1.01) | 0.53 (0.44–0.64) | 0.40 (0.33–0.49) | <0.0001 | 0.0005 | |
| Median 18:2n6/18:3n6 ratio | 0.011 | 0.016 | 0.020 | 0.028 | |||
| AO prevalence, n (%) | 231 (24) | 271 (28) | 356 (36) | 482 (49) | |||
| OR (95% CI) | |||||||
| Sex-adjusted | 1.00 (reference) | 1.24 (1.01–1.52) | 1.86 (1.53–2.27) | 3.19 (2.63–3.89) | <0.0001 | 0.0021 | |
| Multivariable-adjusted | 1.00 (reference) | 1.19 (0.97–1.47) | 1.78 (1.45–2.17) | 3.00 (2.45–3.66) | <0.0001 | 0.0038 | |
1D5D, Δ5-desaturase; D6D, Δ6-desaturase; SAD, sagittal abdominal diameter; SCD, stearoyl-CoA desaturase WC, waist circumference; WHR, waist-hip ratio.
2P for overall trend (Ptrend) was evaluated using logistic regression models with sex-specific quartile median as exposure.
3P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines.
4Abdominal obesity was defined as WC>88 cm in women and WC>102 cm in men.
5OR and 95% CI were evaluated using logistic regression models.
6Adjusted for sex, physical activity, alcohol intake, education and smoking.
Associations of estimated desaturase activities with anthropometric measures.,.
| Quartile of estimated desaturase activity | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | Ptrend | Pnon-linear | |||
| SAD, cm | Observed | 19.5 (19.4–19.7) | 20.2 (20.0–20.3) | 21.0 (20.9–21.2) | 21.6 (21.4–21.8) | <0.0001 | <0.0001 | |
| Adjusted | 19.5 (19.4–19.7) | 20.2 (20.0–20.3) | 21.0 (20.9–21.2) | 21.6 (21.5–21.8) | <0.0001 | <0.0001 | ||
| WC, cm | Observed | 87.4 (86.7–88.2) | 90.5 (89.8–91.2) | 93.9 (93.1–94.7) | 95.8 (95.0–96.6) | <0.0001 | <0.0001 | |
| Adjusted | 87.4 (86.7–88.1) | 90.5 (89.8–91.2) | 93.9 (93.2–94.5) | 95.9 (95.2–96.6) | <0.0001 | <0.0001 | ||
| WHR, cm | Observed | 0.87 (0.86–0.87) | 0.88 (0.88–0.89) | 0.89 (0.89–0.90) | 0.91 (0.90–0.91) | <0.0001 | <0.0001 | |
| Adjusted | 0.87 (0.86–0.87) | 0.88 (0.88–0.88) | 0.89 (0.89–0.90) | 0.91 (0.90–0.91) | <0.0001 | <0.0001 | ||
| SAD, cm | Observed | 21.4 (21.2–21.6) | 20.9 (20.7–21.0) | 20.3 (20.1–20.5) | 19.8 (19.6–20.0) | <0.0001 | <0.0001 | |
| Adjusted | 21.4 (21.2–21.6) | 20.9 (20.7–21.0) | 20.3 (20.1–20.5) | 19.8 (19.6–20.0) | <0.0001 | <0.0001 | ||
| WC, cm | Observed | 95.2 (94.5–96.0) | 92.9 (92.1–93.7) | 90.7 (89.9–91.5) | 88.8 (88.0–89.5) | <0.0001 | <0.0001 | |
| Adjusted | 95.1 (94.4–95.8) | 92.9 (92.3–93.6) | 90.7 (90.1–91.4) | 88.8 (88.2–89.5) | <0.0001 | <0.0001 | ||
| WHR, cm | Observed | 0.90 (0.90–0.91) | 0.89 (0.89–0.90) | 0.88 (0.88–0.89) | 0.87 (0.87–0.88) | <0.0001 | 0.0005 | |
| Adjusted | 0.90 (0.90–0.91) | 0.89 (0.89–0.90) | 0.88 (0.88–0.89) | 0.87 (0.87–0.88) | <0.0001 | 0.0005 | ||
| SAD, cm | Observed | 19.7 (19.6–19.9) | 20.2 (20.1–20.4) | 20.8 (20.6–21.0) | 21.6 (21.4–21.8) | <0.0001 | <0.0001 | |
| Adjusted | 19.8 (19.6–20.0) | 20.2 (20.1–20.4) | 20.8 (20.6–21.0) | 21.5 (21.4–21.7) | <0.0001 | 0.0001 | ||
| WC, cm | Observed | 88.4 (87.6–89.1) | 90.5 (89.7–91.3) | 93.0 (92.2–93.7) | 95.8 (95.0–96.5) | <0.0001 | <0.0001 | |
| Adjusted | 88.6 (88.0–89.3) | 90.5 (89.9–91.2) | 92.9 (92.2–93.6) | 95.5 (94.9–96.2) | <0.0001 | <0.0001 | ||
| WHR, cm | Observed | 0.87 (0.86–0.87) | 0.88 (0.87–0.89) | 0.89 (0.89–0.90) | 0.91 (0.90–0.91) | <0.0001 | <0.0001 | |
| Adjusted | 0.87 (0.87–0.88) | 0.88 (0.88–0.88) | 0.89 (0.89–0.90) | 0.90 (0.90–0.91) | <0.0001 | <0.0001 | ||
1D5D, Δ5-desaturase; D6D, Δ6-desaturase; SAD, sagittal abdominal diameter; SCD, stearoyl-CoA desaturase; WC, waist circumference; WHR, waist-hip ratio.
2Values are quartile means (95% CI).
3P for overall trend (Ptrend) was evaluated linear regression models with sex-specific quartile median as exposure; for observed values sex was the only additional covariate, while for multivariable-adjusted trend sex,physical activity, alcohol intake, education and smoking were included as covariates.
4P for nonlinearity (Pnon-linear) was evaluated using restricted cubic splines.
5Values were adjusted for sex, physical activity, alcohol intake, education and smoking.